Olink™ proteomics enables high-throughput protein biomarker profiling across human plasma, serum, cerebrospinal fluid (CSF) and other sample types. Using Proximity Extension Assay (PEA) technology, Olink™ combines antibody-based target recognition with next-generation sequencing readout to quantify large numbers of proteins with high specificity and sensitivity.
Novogene Europe provides Olink™ proteomics services to support biomarker discovery, disease mechanism research and multi-omics studies. With Olink™ Explore HT and Olink™ Reveal options, researchers can profile broad protein panels for exploratory discovery or focused inflammation and immune-related research.




